Antisense to CDK4 inhibits the growth of human colon cancer cells HT29

National Medical Journal of China

Volumn 86, Issue 12, 2006, Pages 846-849

  Ye, Ying Jiang ^a   Zhu, Xue Guang ^a   Wang, Shan ^a   Wang, Yong Chao ^a   Sang, Jian Li ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Antisense RNA; CDK4; Cell line; Colorectal carcinoma

Indexed keywords

COMPLEMENTARY RNA; CYCLIN DEPENDENT KINASE 4; LIPOFECTAMINE; MESSENGER RNA;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE ARREST; CELL CYCLE G1 PHASE; CELL GROWTH; CELL PROLIFERATION; CELL STRAIN HT29; CELL TRANSFORMATION; COLON CANCER; COLONY FORMATION; COLORECTAL CARCINOMA; DOWN REGULATION; DRUG ACTIVITY; FLOW CYTOMETRY; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NORTHERN BLOTTING; PHENOTYPE; PROTEIN SYNTHESIS INHIBITION; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL CYCLE; CELL PROLIFERATION; COLONIC NEOPLASMS; CYCLIN-DEPENDENT KINASE 4; DNA, ANTISENSE; HT29 CELLS; HUMANS; MICROSCOPY, FLUORESCENCE; RNA, MESSENGER; TRANSFECTION;

EID: 33646057310     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Collins K, Tyler J, Pavletich NP, et al. The cell cycle and cancer. Proc Natl Acad Sci USA, 1997,94:2776-2778.
2. Fitzgerald MG, Harkin DP, Silva Arrieta S, et al. Prevalence of germ-line mutations in p16, p19ARF, and CDK4 in familial melanoma: analysis of a cilinic-based population. Proc nat Acad Sci, 1996,93:8541-8545.
3. Jiang W, Zhang YJ, Kahn S, Hollstein M, et al. Altered expression of the cyclin D1 and retinoblastoma genes in human esophageal cancer. Pro Natl Acad Sci USA, 1992,90:9026-9030.
4. Weinstein IB and Zhou P. Cell cycle control gene defects and human cancer, In: J. R. Bertino(ed), Encyclopedia Cancer, Vol 1, pp. 256-267 New York: Academic Press, 1996.
5. Arber N, Doki Y, Han EK-H, et al. Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon. Cancer Res, 1997; 57:1569-1574.
6. Ikeda K, Monden T, Tsujie M, et al. Cyclin D, CDK4 and p16expression in colorectal cancer. Nippon Rinsho, 1996,54:1054-1059
7. Zhang T, Nanney LB, Luongo C, et al. Concurrent overecpression of cyclin D1 and cyclin-dependent kinase 4 (Cdk4) intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenomatous polyposis patients. Cancer Res,1997,57:169-175.
8. Chinese source. CDK4 2000,15:370-372.
9. Soni R, O'Reilly T, Furet P, et al. Selective in vivo and in vitro effects of a small molecule inhibitor of cyclin-dependent kinase 4. J Natl Cancer Inst, 2001,93:436-446.
10. Yu B, Lane ME, Wakler S. SU9516, a cyclin-dependent kinase 2 inhibitor, promotes accumulation of high molecular weight E2F complexes in human colon carcinoma cells. Biochemical Pharm. acology, 2002,64:1091-1100.
11. Yu B, Lane ME, Pestell RG et al. Downregulation of cyclin D1 alters cdk 4- and cdk 2-specific phosphorylation of retinoblastoma protein. Eur J Cancer, 2002,38:2446-2454.
12. Maclachlan TK, Sang N and Giordano A. Cyclins, cyclin-dependent kinases and cdk inhibitors: Implications in cell cyclie control and cancer. Crit Rev Eukaryot Gene Expr, 1995,121:633-647.
13. Gill RM. Characterization of the human RB1 promoter and of elements involved in transcriptional regulation. Cell Growth Diff, 1994,5:467-474.
14. Tam SW, Theodoras AM, Shay JW, et al. Differential expression and regulation of cyclin D1 protein in normal and tumor human cells: association with cdk4 is required for cyclin D1 function in G1. Oncogene, 1994,9:2663-2674.
15. Sandg V. Aenovially transferred p16 INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death. Nature Med, 1997, 57:4838-4848.